Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.

Jacobs BA, Pando MM, Jennings EM, Jamshidi RJ, Zamora JC, Chavera TS, Clarke WP, Berg KA.

Neuropharmacology. 2019 Jun;151:208-218. doi: 10.1016/j.neuropharm.2019.02.019. Epub 2019 Feb 15.

PMID:
30776373
2.

Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.

Berg KA, Clarke WP.

Int J Neuropsychopharmacol. 2018 Oct 1;21(10):962-977. doi: 10.1093/ijnp/pyy071. Review.

3.

Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Jacobs BA, Pando MM, Jennings E, Chavera TA, Clarke WP, Berg KA.

Mol Pharmacol. 2018 Apr;93(4):376-386. doi: 10.1124/mol.117.109975. Epub 2018 Feb 7.

4.

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.

LoCoco PM, Risinger AL, Smith HR, Chavera TS, Berg KA, Clarke WP.

Elife. 2017 Nov 10;6. pii: e29626. doi: 10.7554/eLife.29626.

5.

Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Sullivan LC, Chavera TA, Gao X, Pando MM, Berg KA.

J Pharmacol Exp Ther. 2017 Jul;362(1):200-209. doi: 10.1124/jpet.117.241604. Epub 2017 May 2. Erratum in: J Pharmacol Exp Ther. 2019 Apr;369(1):143.

6.

Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.

Higgins GA, Silenieks LB, Patrick A, De Lannoy IAM, Fletcher PJ, Parker LA, MacLusky NJ, Sullivan LC, Chavera TA, Berg KA.

ACS Chem Neurosci. 2017 May 17;8(5):1074-1084. doi: 10.1021/acschemneuro.6b00444. Epub 2017 Mar 24.

PMID:
28338324
7.

Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Sullivan LC, Chavera TS, Jamshidi RJ, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2016 Dec;359(3):411-419. Epub 2016 Sep 22.

8.
9.

Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Jamshidi RJ, Jacobs BA, Sullivan LC, Chavera TA, Saylor RM, Prisinzano TE, Clarke WP, Berg KA.

J Pharmacol Exp Ther. 2015 Nov;355(2):174-82. doi: 10.1124/jpet.115.225896. Epub 2015 Aug 21.

10.

Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Sullivan LC, Clarke WP, Berg KA.

Curr Pharm Des. 2015;21(26):3732-8.

11.

Divergence in endothelin-1- and bradykinin-activated store-operated calcium entry in afferent sensory neurons.

Szteyn K, Gomez R, Berg KA, Jeske NA.

ASN Neuro. 2015 Apr 13;7(2). pii: 1759091415578714. doi: 10.1177/1759091415578714. Print 2015 Mar-Apr.

12.

Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons.

Sullivan LC, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2015 Apr;353(1):44-51. doi: 10.1124/jpet.114.221366. Epub 2015 Jan 30.

13.

Interleukin-6 attenuates serotonin 2a receptor signaling by activating the JAK-STAT pathway.

Donegan JJ, Patton MS, Chavera TS, Berg KA, Morilak DA, Girotti M.

Mol Pharmacol. 2015;87(3):492-500. doi: 10.1124/mol.114.096289. Epub 2014 Dec 30.

14.

G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.

Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LM.

J Biol Chem. 2014 Aug 8;289(32):22117-27. doi: 10.1074/jbc.M114.566893. Epub 2014 Jun 24.

15.

Activation of estrogen receptor α enhances bradykinin signaling in peripheral sensory neurons of female rats.

Rowan MP, Berg KA, Roberts JL, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2014 Jun;349(3):526-32. doi: 10.1124/jpet.114.212977. Epub 2014 Apr 4.

16.

β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel.

Por ED, Bierbower SM, Berg KA, Gomez R, Akopian AN, Wetsel WC, Jeske NA.

J Biol Chem. 2012 Oct 26;287(44):37552-63. doi: 10.1074/jbc.M112.391847. Epub 2012 Sep 5.

17.

Receptor and channel heteromers as pain targets.

Berg KA, Patwardhan AM, Akopian AN.

Pharmaceuticals (Basel). 2012 Feb 23;5(3):249-78. doi: 10.3390/ph5030249.

18.

Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.

Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, Clarke WP.

Mol Pharmacol. 2012 Feb;81(2):264-72. doi: 10.1124/mol.111.072702. Epub 2011 Nov 9.

19.

A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphate.

Jeske NA, Por ED, Belugin S, Chaudhury S, Berg KA, Akopian AN, Henry MA, Gomez R.

J Neurosci. 2011 Jun 8;31(23):8681-8. doi: 10.1523/JNEUROSCI.0020-11.2011.

20.

Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Berg KA, Rowan MP, Sanchez TA, Silva M, Patwardhan AM, Milam SB, Hargreaves KM, Clarke WP.

J Pharmacol Exp Ther. 2011 Jul;338(1):92-9. doi: 10.1124/jpet.110.177493. Epub 2011 Apr 12.

Supplemental Content

Loading ...
Support Center